Skip to main content

Study

Preserving Muscle During Weight Loss in Older Adults

Incretin-based therapies can lead to muscle loss during weight reduction; exercise and adequate protein intake help preserve muscle strength.

Heart Health
Study Credibility: Medium5.8/10Some supporting evidenceStudy has limitationsUse with caution
PublishedDec 2025Last reviewedJan 2026
Email this

Summary

In plain language

Researchers have discovered that while incretin-based therapies used for weight loss in older adults can lead to a reduction in muscle mass, maintaining muscle is crucial for long-term health benefits. The study showed that 25–40% of weight loss from these therapies may come from losing lean muscle. To counteract this, strategies such as regular exercise, proper protein intake, and potentially new treatments can help maintain muscle mass. This is important because muscle health is key to cardiovascular health and overall well-being. Seniors using these therapies might want to discuss muscle-preserving strategies with their healthcare providers.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This narrative review highlights skeletal muscle as a key therapeutic target for cardiometabolic health. It discusses how creatine supplementation, alongside protein intake and exercise, may preserve muscle and reduce cardiovascular risk in aging adults.

Research Quality Score

Scored January 20, 2026 using rubric v5_2025-02-01.

Assessment

The study is a narrative review that provides an overview of existing literature on the role of muscle preservation in cardiometabolic health. While it highlights an important area for future research, the study design inherently limits the level of evidence provided. The study is transparent about its scope and limitations, and it is published in a reputable journal.

Category Breakdown

CategoryScoreRating
Study design5.0/10
Bias control5.0/10
Statistical methods5.0/10
Reporting completeness5.0/10
Conflicts & funding10.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability7.5/10

Additional Notes

The study effectively identifies gaps in current research and suggests areas for future clinical trials. However, the lack of original data and potential for selection bias in the literature reviewed are notable limitations.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.